The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Structural Heart Disease Treatment Devices-Global Market Insights and Sales Trends 2024
Synopsis
Structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart.
The global Structural Heart Disease Treatment Devices market size is expected to reach US$ 22330 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Structural Heart Disease Treatment Devices in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers and Others,, are propelling Structural Heart Disease Treatment Devices market. Repair Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Replacement Devices segment is estimated at % CAGR for the next seven-year period.
North Americas accounted for the maximum growth of the cardiovascular devices market during 2017. With the growing preference for tissue heart valves over mechanical heart valves and the increased popularity of MI and transcatheter procedures in the developed economies such as the US, this region will account for the maximum growth of this market during the next few years as well.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Structural Heart Disease Treatment Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Structural Heart Disease Treatment Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Structural Heart Disease Treatment Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Structural Heart Disease Treatment Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Structural Heart Disease Treatment Devices covered in this report include Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology and Medtronic, etc.
The global Structural Heart Disease Treatment Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Boston Scientific
Edwards Lifesciences
LivaNova
Lepu Medical Technology
Medtronic
Global Structural Heart Disease Treatment Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Structural Heart Disease Treatment Devices market, Segment by Type:
Repair Devices
Replacement Devices
Global Structural Heart Disease Treatment Devices market, by Application
Hospitals
Ambulatory Surgery Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Structural Heart Disease Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Structural Heart Disease Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart.
The global Structural Heart Disease Treatment Devices market size is expected to reach US$ 22330 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Structural Heart Disease Treatment Devices in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers and Others,, are propelling Structural Heart Disease Treatment Devices market. Repair Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Replacement Devices segment is estimated at % CAGR for the next seven-year period.
North Americas accounted for the maximum growth of the cardiovascular devices market during 2017. With the growing preference for tissue heart valves over mechanical heart valves and the increased popularity of MI and transcatheter procedures in the developed economies such as the US, this region will account for the maximum growth of this market during the next few years as well.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Structural Heart Disease Treatment Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Structural Heart Disease Treatment Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Structural Heart Disease Treatment Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Structural Heart Disease Treatment Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Structural Heart Disease Treatment Devices covered in this report include Abbott, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology and Medtronic, etc.
The global Structural Heart Disease Treatment Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Boston Scientific
Edwards Lifesciences
LivaNova
Lepu Medical Technology
Medtronic
Global Structural Heart Disease Treatment Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Structural Heart Disease Treatment Devices market, Segment by Type:
Repair Devices
Replacement Devices
Global Structural Heart Disease Treatment Devices market, by Application
Hospitals
Ambulatory Surgery Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Structural Heart Disease Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Structural Heart Disease Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Structural Heart Disease Treatment Devices Market Overview
1.1 Structural Heart Disease Treatment Devices Product Overview
1.2 Structural Heart Disease Treatment Devices Market Segment by Type
1.2.1 Repair Devices
1.2.2 Replacement Devices
1.3 Global Structural Heart Disease Treatment Devices Market Size by Type
1.3.1 Global Structural Heart Disease Treatment Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Structural Heart Disease Treatment Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Structural Heart Disease Treatment Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Structural Heart Disease Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Structural Heart Disease Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Structural Heart Disease Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Structural Heart Disease Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Structural Heart Disease Treatment Devices Sales Breakdown by Type (2018-2023)
2 Global Structural Heart Disease Treatment Devices Market Competition by Company
2.1 Global Top Players by Structural Heart Disease Treatment Devices Sales (2018-2023)
2.2 Global Top Players by Structural Heart Disease Treatment Devices Revenue (2018-2023)
2.3 Global Top Players by Structural Heart Disease Treatment Devices Price (2018-2023)
2.4 Global Top Manufacturers Structural Heart Disease Treatment Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Structural Heart Disease Treatment Devices Market Competitive Situation and Trends
2.5.1 Structural Heart Disease Treatment Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Structural Heart Disease Treatment Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Structural Heart Disease Treatment Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Structural Heart Disease Treatment Devices Market
2.8 Key Manufacturers Structural Heart Disease Treatment Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Structural Heart Disease Treatment Devices Status and Outlook by Region
3.1 Global Structural Heart Disease Treatment Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Structural Heart Disease Treatment Devices Historic Market Size by Region
3.2.1 Global Structural Heart Disease Treatment Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Structural Heart Disease Treatment Devices Sales in Value by Region (2018-2023)
3.2.3 Global Structural Heart Disease Treatment Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Structural Heart Disease Treatment Devices Forecasted Market Size by Region
3.3.1 Global Structural Heart Disease Treatment Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Structural Heart Disease Treatment Devices Sales in Value by Region (2024-2029)
3.3.3 Global Structural Heart Disease Treatment Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Structural Heart Disease Treatment Devices by Application
4.1 Structural Heart Disease Treatment Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgery Centers
4.1.3 Others
4.2 Global Structural Heart Disease Treatment Devices Market Size by Application
4.2.1 Global Structural Heart Disease Treatment Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Structural Heart Disease Treatment Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Structural Heart Disease Treatment Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Structural Heart Disease Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Structural Heart Disease Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Structural Heart Disease Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Structural Heart Disease Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Structural Heart Disease Treatment Devices Sales Breakdown by Application (2018-2023)
5 North America Structural Heart Disease Treatment Devices by Country
5.1 North America Structural Heart Disease Treatment Devices Historic Market Size by Country
5.1.1 North America Structural Heart Disease Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Structural Heart Disease Treatment Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Structural Heart Disease Treatment Devices Sales in Value by Country (2018-2023)
5.2 North America Structural Heart Disease Treatment Devices Forecasted Market Size by Country
5.2.1 North America Structural Heart Disease Treatment Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Structural Heart Disease Treatment Devices Sales in Value by Country (2024-2029)
6 Europe Structural Heart Disease Treatment Devices by Country
6.1 Europe Structural Heart Disease Treatment Devices Historic Market Size by Country
6.1.1 Europe Structural Heart Disease Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Structural Heart Disease Treatment Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Structural Heart Disease Treatment Devices Sales in Value by Country (2018-2023)
6.2 Europe Structural Heart Disease Treatment Devices Forecasted Market Size by Country
6.2.1 Europe Structural Heart Disease Treatment Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Structural Heart Disease Treatment Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Structural Heart Disease Treatment Devices by Region
7.1 Asia-Pacific Structural Heart Disease Treatment Devices Historic Market Size by Region
7.1.1 Asia-Pacific Structural Heart Disease Treatment Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Structural Heart Disease Treatment Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Structural Heart Disease Treatment Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Structural Heart Disease Treatment Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Structural Heart Disease Treatment Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Structural Heart Disease Treatment Devices Sales in Value by Region (2024-2029)
8 Latin America Structural Heart Disease Treatment Devices by Country
8.1 Latin America Structural Heart Disease Treatment Devices Historic Market Size by Country
8.1.1 Latin America Structural Heart Disease Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Structural Heart Disease Treatment Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Structural Heart Disease Treatment Devices Sales in Value by Country (2018-2023)
8.2 Latin America Structural Heart Disease Treatment Devices Forecasted Market Size by Country
8.2.1 Latin America Structural Heart Disease Treatment Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Structural Heart Disease Treatment Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Structural Heart Disease Treatment Devices by Country
9.1 Middle East and Africa Structural Heart Disease Treatment Devices Historic Market Size by Country
9.1.1 Middle East and Africa Structural Heart Disease Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Structural Heart Disease Treatment Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Structural Heart Disease Treatment Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Structural Heart Disease Treatment Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Structural Heart Disease Treatment Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Structural Heart Disease Treatment Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Structural Heart Disease Treatment Devices Products Offered
10.1.5 Abbott Recent Development
10.2 Boston Scientific
10.2.1 Boston Scientific Company Information
10.2.2 Boston Scientific Introduction and Business Overview
10.2.3 Boston Scientific Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boston Scientific Structural Heart Disease Treatment Devices Products Offered
10.2.5 Boston Scientific Recent Development
10.3 Edwards Lifesciences
10.3.1 Edwards Lifesciences Company Information
10.3.2 Edwards Lifesciences Introduction and Business Overview
10.3.3 Edwards Lifesciences Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Edwards Lifesciences Structural Heart Disease Treatment Devices Products Offered
10.3.5 Edwards Lifesciences Recent Development
10.4 LivaNova
10.4.1 LivaNova Company Information
10.4.2 LivaNova Introduction and Business Overview
10.4.3 LivaNova Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LivaNova Structural Heart Disease Treatment Devices Products Offered
10.4.5 LivaNova Recent Development
10.5 Lepu Medical Technology
10.5.1 Lepu Medical Technology Company Information
10.5.2 Lepu Medical Technology Introduction and Business Overview
10.5.3 Lepu Medical Technology Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lepu Medical Technology Structural Heart Disease Treatment Devices Products Offered
10.5.5 Lepu Medical Technology Recent Development
10.6 Medtronic
10.6.1 Medtronic Company Information
10.6.2 Medtronic Introduction and Business Overview
10.6.3 Medtronic Structural Heart Disease Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Medtronic Structural Heart Disease Treatment Devices Products Offered
10.6.5 Medtronic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Structural Heart Disease Treatment Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Structural Heart Disease Treatment Devices Industrial Chain Analysis
11.4 Structural Heart Disease Treatment Devices Market Dynamics
11.4.1 Structural Heart Disease Treatment Devices Industry Trends
11.4.2 Structural Heart Disease Treatment Devices Market Drivers
11.4.3 Structural Heart Disease Treatment Devices Market Challenges
11.4.4 Structural Heart Disease Treatment Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Structural Heart Disease Treatment Devices Distributors
12.3 Structural Heart Disease Treatment Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
